About CellPath
CellPath was founded in 1969 and is located in Newtown, United Kingdom. Laboratory equipment is manufactured and supplied to support research activities. Product development services are offered to assist in innovation and testing processes. Operations focus on the scientific sector, providing tools and expertise for laboratory environments across the region. The company maintains a domain at cellpath.com for its activities.
- Headquarter Newtown, United Kingdom
- SectorsHealthcareIndustrial Goods & Manufacturing
- Email••••••••
- Phone•••• ••••
- Website cellpath.com
- Social LinkedIn X
- Acquired by StatLab (Jun 2022)
Funding Insights of CellPath
- Total Rounds 1
- Last Round Grant — $518,323
- First Round $518,323
(Jan 2014)
- Investors Count 1
All 1 funding rounds of CellPath with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2014 | $518,323 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in CellPath
CellPath has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include StatLab and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Consumable supplies for histology, cytology, and immunohistochemistry are developed. | 1976 | statlab.com | Mckinney, United States |
Investor details for CellPath
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CellPath
3 dated milestones of CellPath across 53 years, from founding to its latest funding, stage changes and deals.
- Founded CellPath is founded.
- Funding First funding round of $518K.
- Exit Acquired by StatLab.
Web traffic of CellPath
The website of CellPath (cellpath.com) receives about 9.8K visits a month.
- Monthly visits9.8K
▲ 10.6% vs previous month
Websites whose visitors overlap most with CellPath. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mopec.com | 100% | 18.2K | #1,493,355 | View details | |
| sakuraus.com | 97% | 17.8K | #1,495,972 | View details | |
henryschein.ca | henryschein.ca | 78% | – | #463,424 | – |
| wms.co.uk | 47% | 69.4K | #529,193 | View details |
Similar companies to CellPath
10 companies that operate in the same segment as CellPath (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CellPath
CellPath was founded in 1969 and raised its 1st funding round 45 years after it was founded.
CellPath is headquartered in Newtown, United Kingdom. It is registered at Newtown, Powys, United Kingdom.
CellPath was founded in 1969 and is located in Newtown, United Kingdom. Laboratory equipment is manufactured and supplied to support research activities. Product development services are offered to assist in innovation and testing processes. Operations focus on the scientific sector, providing tools and expertise for laboratory environments across the region. The company maintains a domain at cellpath.com for its activities.
CellPath has 2 investors. Key investors include StatLab, and European Union.
Yes. CellPath was acquired by StatLab in June 2022.